therapeutics-cell Videos
13 videos found
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, that will enable millions of patients to access the medical revolution of cell therapy by overcoming its main manufacturing ...
Jul. 13, 2022
Incorporated in Bordeaux, France, in 2018, TreeFrog Therapeutics aims to provide access to safe and affordable cell therapies for millions of patients. TreeFrog Therapeutics has developed C-Stem™, a high-throughput cell encapsulation technology allowing for the mass-production and differentiation of stem ...
Jul. 13, 2022
A quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell ...
Jul. 13, 2022
Highlighting the progress made by Kris Boesen and Lucas Lindner, both of whom received Lineage's OPC1 cell therapy following traumatic spinal cord injury ...
Jul. 15, 2022
Ali Tehrani is the co-founder and CEO of Zymeworks, one of the most successful biotech companies to emerge from Vancouver. He sits down to talk about the history of his company, going public and the challenges ahead for startups in B.C.'s life sciences sector. Tyler Orton ...
Jun. 18, 2022
Short white-board video explaining the APOSEC story: paradigm change from stem cells to paracrine factors derived from white blood cells as therapeutic agent in regenerative medicine ...
Sep. 3, 2021
Adipose tissue derived stem cell therapeutic product for ...
Jun. 3, 2022
See how the SCI-tive hypoxia workstation makes a difference to Prof. Nicholas Forsyth from Keele University as he works with mesenchymal stem cells. ...
Apr. 18, 2020
ByBaker
Pluristem's cell manufacturing technology - PLX Bioreactor 3D system, is integrated into the world’s most advanced, automated and aseptic cell production facility, in which we can manufacture large quantities of cells of the highest quality in a cost-effective, reproducible and consistent manner. ...
May. 31, 2022
Cell therapy company TreeFrog Therapeutics is powering The Stem Cell SpaceShot Grant - a $100,000 research funding in the field of stem cell biology and regenerative medicine. It’s open to PhD-level scientists and PhD students conducting research in stem cell biology, biophysics, gene editing, ...
Jul. 13, 2022
Our data-driven research platforms empower scientists to create a comprehensive understanding of tumor cell biology, therapeutic dynamics and provide rapid clinical ...
Feb. 1, 2023
Racheli Ofir, VP Research & Intellectual Property, sharing insights on PLX-R18’s unique mechanism of action and therapeutic potential for the treatment of hematology deficiencies. Pluristem’s PLX R-18 cell therapy has the potential to generate improved blood counts in all three blood cell lineages. About Us: Pluristem ...
May. 31, 2022